College of Medicine & Public Health, Flinders University of South Australia, Adelaide (D.P.C., A.B., A.S., J.K., A.C., E.M.).
South Australian Health and Medical Research Institute, Adelaide (D.P.C., A.J.C.).
Circulation. 2019 Nov 5;140(19):1543-1556. doi: 10.1161/CIRCULATIONAHA.119.042891. Epub 2019 Sep 3.
High-sensitivity troponin assays promise earlier discrimination of myocardial infarction. Yet, the benefits and harms of this improved discriminatory performance when incorporated within rapid testing protocols, with respect to subsequent testing and clinical events, has not been evaluated in an in-practice patient-level randomized study. This multicenter study evaluated the noninferiority of a 0/1-hour high-sensitivity cardiac troponin T (hs-cTnT) protocol in comparison with a 0/3-hour masked hs-cTnT protocol in patients with suspected acute coronary syndrome presenting to the emergency department (ED).
Patients were randomly assigned to either a 0/1-hour hs-cTnT protocol (reported to the limit of detection [<5 ng/L]) or masked hs-cTnT reported to ≤29 ng/L evaluated at 0/3-hours (standard arm). The 30-day primary end point was all-cause death and myocardial infarction. Noninferiority was defined as an absolute margin of 0.5% determined by Poisson regression.
In total, 3378 participants with an emergency presentation were randomly assigned between August 2015 and April 2019. Ninety participants were deemed ineligible or withdrew consent. The remaining participants received care guided either by the 0/1-hour hs-cTnT protocol (n=1646) or the 0/3-hour standard masked hs-cTnT protocol (n=1642) and were followed for 30 days. Median age was 59 (49-70) years, and 47% were female. Participants in the 0/1-hour arm were more likely to be discharged from the ED (0/1-hour arm: 45.1% versus standard arm: 32.3%, <0.001) and median ED length of stay was shorter (0/1-hour arm: 4.6 [interquartile range, 3.4-6.4] hours versus standard arm: 5.6 (interquartile range, 4.0-7.1) hours, <0.001). Those randomly assigned to the 0/1-hour protocol were less likely to undergo functional cardiac testing (0/1-hour arm: 7.5% versus standard arm: 11.0%, <0.001). The 0/1-hour hs-cTnT protocol was not inferior to standard care (0/1-hour arm: 17/1646 [1.0%] versus 16/1642 [1.0%]; incidence rate ratio, 1.06 [ 0.53-2.11], noninferiority value=0.006, superiority value=0.867), although an increase in myocardial injury was observed. Among patients discharged from ED, the 0/1-hour protocol had a negative predictive value of 99.6% (95% CI, 99.0-99.9%) for 30-day death or myocardial infarction.
This in-practice evaluation of a 0/1-hour hs-cTnT protocol embedded in ED care enabled more rapid discharge of patients with suspected acute coronary syndrome. Improving short-term outcomes among patients with newly recognized troponin T elevation will require an evolution in management strategies for these patients.
URL: https://www.anzctr.org.au. Unique identifier: ACTRN12615001379505.
高敏肌钙蛋白检测有望更早地区分心肌梗死。然而,在实际应用中,将这种改进的区分性能纳入快速检测方案中,对于后续检测和临床事件的影响,尚未在患者水平的随机研究中进行评估。本多中心研究评估了在疑似急性冠脉综合征患者中,与 0/3 小时的 hs-cTnT 检测方案(检测到 <29ng/L 时进行报告)相比,0/1 小时高敏肌钙蛋白 T(hs-cTnT)检测方案的非劣效性,该检测方案报告检测到的 hs-cTnT 浓度到检测限(<5ng/L)。
患者被随机分配到 0/1 小时 hs-cTnT 检测方案组(报告检测到的 hs-cTnT 浓度到检测限[<5ng/L])或 0/3 小时 hs-cTnT 检测方案组(检测到的 hs-cTnT 浓度报告到 <29ng/L)。30 天的主要终点是全因死亡和心肌梗死。非劣效性定义为通过泊松回归确定的 0.5%绝对差值。
共纳入 2015 年 8 月至 2019 年 4 月在急诊就诊的 3378 名患者。90 名患者被认为不符合条件或撤回了同意。其余患者接受了 0/1 小时 hs-cTnT 检测方案(n=1646)或 0/3 小时标准 hs-cTnT 检测方案(n=1642)的指导,并随访 30 天。中位年龄为 59 岁(49-70 岁),47%为女性。0/1 小时组的患者更有可能从急诊室出院(0/1 小时组:45.1%,标准组:32.3%,<0.001),急诊室留观时间更短(0/1 小时组:4.6[四分位间距,3.4-6.4]小时,标准组:5.6[四分位间距,4.0-7.1]小时,<0.001)。随机分配到 0/1 小时方案的患者更不可能进行功能心脏检查(0/1 小时组:7.5%,标准组:11.0%,<0.001)。0/1 小时 hs-cTnT 检测方案并不劣于标准治疗(0/1 小时组:17/1646[1.0%],标准组:16/1642[1.0%];发生率比,1.06[0.53-2.11],非劣效性值=0.006,优效性值=0.867),尽管观察到心肌损伤增加。在从急诊室出院的患者中,0/1 小时方案对 30 天内死亡或心肌梗死的阴性预测值为 99.6%(95%CI,99.0-99.9%)。
本研究在急诊护理中对 0/1 小时 hs-cTnT 检测方案进行了实际应用,使疑似急性冠脉综合征患者的出院速度更快。改善新发现的肌钙蛋白 T 升高患者的短期预后,需要对这些患者的管理策略进行演变。